Lisa Fitzgerald, APRN
Acute Care · San Antonio, TXNPI 1568942571
Payments from drug & device makers
Across 43 payments — averaging $84.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$3K
- Novartis$149
- Chiesi USA, Inc.$110
- Mallinckrodt Hospital Products Inc.$82
- Baxter Healthcare$64
- Takeda Pharmaceuticals U.S.A., Inc.$49
- plus $192 from 7 others
What the payments were for
- Consulting fees$1,58044%
- Travel & lodging$57616%
- Food & beverage$1,26735%
- Education$973%
- Gifts$1103%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 21 | $2,984 |
| Novartis | 5 | $149 |
| Chiesi USA, Inc. | 2 | $110 |
| Mallinckrodt Hospital Products Inc. | 3 | $82 |
| Baxter Healthcare | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Davol Inc. | 2 | $39 |
| Apellis Pharmaceuticals, Inc. | 1 | $34 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Amgen | 1 | $26 |
| One Lambda, Inc. | 1 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Brainscope Company, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$2,275
How this compares
$3,630 in reported general payments places this provider in the 90th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 35 | $27,577 |
| TradjentaLinagliptin | 29 | $17,383 |
| Cinacalcet Hcl | 39 | $16,102 |
| Valganciclovir Hcl | 122 | $14,833 |
| Tacrolimus | 70 | $14,401 |
| Mycophenolate Mofetil | 66 | $6,819 |
| JardianceEmpagliflozin | 11 | $6,654 |
| Cyclosporine ModifiedCyclosporine, Modified | 14 | $1,656 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,125 |
| Cefpodoxime Proxetil | 14 | $955 |
| Nifedipine ErNifedipine | 51 | $847 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 156 | $640 |
| Prednisone | 137 | $530 |
| Cefdinir | 23 | $428 |
| Tamsulosin Hcl | 55 | $258 |
Paid to pharmacies, not to this prescriber.
Other acute care in San Antonio
- Christie MorrisonSan Antonio$225K
- Marc KochSan Antonio$20K
- Jessica BjerkSan Antonio$20K
- Tara CummingSan Antonio$12K
- Erin HernandezSan Antonio$10K
- Daniel ChristensenSan Antonio$8K
- Jill FolkertSan Antonio$8K
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.